Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

Share:
More In Science
Need2Know: January 27, 2023
Five former Memphis police officers were charged with murder in the death of Tyre Nichols, the FDA explores yearly COVID vaccines, and New York City explores electric Uber and Lyft rides. Here is everything you Need2Know for Friday, January 27, 2023.
Load More